Pediatric psychopharmacology. A review with special reference to deanol.
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000627:therapeutic use; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D002220:Carbamazepine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002746:Chlorpromazine / Q000627:therapeutic use; D003642:Deanol / Q000009:adverse effects / Q000627:therapeutic use*; D004827:Epilepsy / Q000503:physiopathology; D004983:Ethanolamines / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007858:Learning / Q000187:drug effects; D008774:Methylphenidate / Q000627:therapeutic use; D010389:Pemoline / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D051381:Rats; D013577:Syndrome; D013881:Thioridazine / Q000627:therapeutic use
D000662:Amphetamines; D000929:Antidepressive Agents, Tricyclic; D004983:Ethanolamines; D008774:Methylphenidate; D003642:Deanol; D002220:Carbamazepine; D010672:Phenytoin; D010389:Pemoline; D013881:Thioridazine; D002746:Chlorpromazine